NEW YORK (GenomeWeb News) - Norwegian company Genpoint has merged with Swedish firm MBS, the companies said today in a joint release.
 
The companies market DNA-analysis instruments and reagents for clinical diagnostics that have been used for tuberculosis, staph infections, and sexually transmitted diseases.
 
Erik Hornes, Genpoint's CEO, said the combined companies will continue to work on bacterial infections and will also shift to viral infections and cancer.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.